HOXA9 Expression is Associated with Advanced Tumour Stage and Prognosis in Nasopharyngeal Carcinoma

References

• Chua MLK , Wee JTS , Hui EP , et al. Nasopharyngeal carcinoma. Lancet . 2016;387(10022):1012–1024. doi:10.1016/S0140-6736(15)00055-0 26321262
   PubMed Web of Science ®Google Scholar
• Chen W , Zheng R , Baade PD , et al. Cancer statistics in China, 2015. CA Cancer J Clin . 2016;66(2):115–132.26808342
   PubMed Web of Science ®Google Scholar
• Chen W , Xia C , Zheng R , et al. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment. Lancet Glob Health . 2019;7(2):e257–e269.30683243
   PubMed Web of Science ®Google Scholar
• Blanchard P , Lee A , Marguet S , et al. MAC-NPC Collaborative Group. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol . 2015;16(6):645–655.25957714
   PubMed Web of Science ®Google Scholar
• Yang L , Xia L , Wang Y , et al. Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma. BMC Cancer . 2017;17(1):628.28874126
   PubMed Web of Science ®Google Scholar
• Quinonez SC , Innis JW . Human HOX gene disorders. Mol Genet Metab . 2014;111(1):4–15.24239177
   PubMed Web of Science ®Google Scholar
• Bhatlekar S , Fields JZ , Boman BM . HOX genes and their role in the development of human cancers. J Mol Med (Berl) . 2014;92(8):811–823.24996520
   PubMed Web of Science ®Google Scholar
• Collins CT , Hess JL . Deregulation of the HOXA9/MEIS1 axis in acute leukemia. Curr Opin Hematol . 2016;23(4):354–361.27258906
   PubMed Web of Science ®Google Scholar
• Janmaat VT , Liu H , da Silva RA , et al. HOXA9 mediates and marks premalignant compartment size expansion in colonic adenomas. Carcinogenesis . 2019;40(12):1514–1524.31099823
   PubMed Web of Science ®Google Scholar
• Qin K , Tian G , Chen G , et al. miR-647 inhibits glioma cell proliferation, colony formation and invasion by regulating HOXA9. J Gene Med . 2020;22(3):e3153.31881106
   PubMed Web of Science ®Google Scholar
• Wrangle J , Machida EO , Danilova L , et al. Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer. Clin Cancer Res . 2014;20(7):1856–1864.24486589
   PubMed Web of Science ®Google Scholar
• Chang SL , Chen TJ , Lee YE , et al. CDKN3 expression is an independent prognostic factor and associated with advanced tumor stage in nasopharyngeal carcinoma. Int J Med Sci . 2018;15(10):992–998.30013440
   PubMed Web of Science ®Google Scholar
• Li J , Ye M , Zhou C . Expression Profile and Prognostic Values of HOXA Family Members in Laryngeal Squamous Cell Cancer. Front Oncol . 2020;10:368.32296636
   PubMed Web of Science ®Google Scholar
• Ramos-Mejía V , Navarro-Montero O , Ayllón V , et al. HOXA9 promotes hematopoietic commitment of human embryonic stem cells. Blood . 2014;124(20):3065–3075.25185710
   PubMed Web of Science ®Google Scholar
• Popovic R , Erfurth F , Zeleznik-le N . Transcriptional complexity of the HOXA9 locus. Blood Cells Mol Dis . 2008;40(2):156–159.17916434
   PubMed Web of Science ®Google Scholar
• Collins CT , Hess JL . Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets. Oncogene . 2016;35(9):1090–1098.26028034
   PubMed Web of Science ®Google Scholar
• Pojo M , Gonçalves CS , Xavier-Magalhães A , et al. A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide. Oncotarget . 2015;6(10):7657–7674.25762636
   PubMedGoogle Scholar
• Costa BM , Smith JS , Chen Y , et al. Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma. Cancer Res . 2010;70(2):453–462.20068170
   PubMed Web of Science ®Google Scholar
• Watanabe Y , Saito M , Saito K , et al. Upregulated HOXA9 expression is associated with lymph node metastasis in colorectal cancer. Oncol Lett . 2018;15(3):2756–2762.29435001
   PubMed Web of Science ®Google Scholar
• Bhatlekar S , Ertel A , Gonye GE , et al. Gene expression signatures for HOXA4, HOXA9, and HOXD10 reveal alterations in transcriptional regulatory networks in colon cancer. J Cell Physiol . 2019;234(8):13042–13056.30552679
   PubMed Web of Science ®Google Scholar
• Hwang JA , Lee BB , Kim Y , et al. HOXA9 inhibits migration of lung cancer cells and its hypermethylation is associated with recurrence in non-small cell lung cancer. Mol Carcinog . 2015;54(Suppl 1):E72–80.24817037
   PubMed Web of Science ®Google Scholar
• Zhao Y , Zheng R , Chen J , et al. CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC). Cancer Cell Int . 2020;20:289.32655321
   PubMed Web of Science ®Google Scholar
• Bhatlekar S , Viswanathan V , Fields JZ , et al. Overexpression of HOXA4 and HOXA9 genes promotes self-renewal and contributes to colon cancer stem cell overpopulation. J Cell Physiol . 2018;233(2):727–735.28464221
   PubMed Web of Science ®Google Scholar
• Ju T , Jin H , Ying R , et al. Overexpression of NAC1 confers drug resistance via HOXA9 in colorectal carcinoma cells. Mol Med Rep . 2017;16(3):3194–3200.28713930
   PubMed Web of Science ®Google Scholar
• Brotto DB , Siena ÁDD , de Barros II , et al. Contributions of HOX genes to cancer hallmarks: enrichment pathway analysis and review. Tumour Biol . 2020;42(5):1010428320918050.32456563
   PubMedGoogle Scholar
• Pai P , Sukumar S . HOX genes and the NF-κB pathway: a convergence of developmental biology, inflammation and cancer biology. Biochim Biophys Acta Rev Cancer . 2020;1874(2):188450.33049277
   PubMed Web of Science ®Google Scholar